2015 Silver Innovator Award

Congratulations to our 2015 Silver Innovator Award Winner, Rudolph E. Tanzi, PhD.


Dr. Rudolph Tanzi serves as Chair of the Cure Alzheimer’s Fund Research Consortium. He is also the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard University and Director of the Genetics and Aging Research Unit at Massachusetts General Hospital (MGH).

Dr. Tanzi has been a pioneer in genetic studies of neurological disease since the 1980’s when he participated in the first study to use genetic markers to find a disease gene (Huntington's disease). Dr. Tanzi co-discovered the three familial early-onset Alzheimer's disease (AD) genes and several other neurological disease genes including that responsible for Wilson’s disease. As leader of the Cure Alzheimer’s Fund Alzheimer’s Genome Project, Dr. Tanzi has carried out multiple genome wide association studies of thousands of Alzheimer’s families leading to the identification of over 100 novel AD candidate genes, including CD33. His research on the role of zinc and copper in AD has led to clinical trials of the drug PBT2. Dr. Tanzi serves on dozens of editorial and scientific advisory boards, and has received the two highest awards for Alzheimer's disease research: The Metropolitan Life Award and The Potamkin Prize. He has published over 425 research articles and  co-authored the popular trade books “Decoding Darkness” and the recent New York Times Bestseller, “Super Brain”.